Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Phase II data for nemolizumab in moderate-to-severe prurigo nodularis

March 4, 2020

Leo Pharma synthesizes new RORgammaT ligands

March 3, 2020

Increasing immune activity improves autoimmunity

March 3, 2020

Leo Pharma A/S presents RORC ligands

Feb. 28, 2020

Positive initial data from phase IIa study of IFX-1 in Pyoderma gangraenosum

Feb. 27, 2020

Tradipitant demonstrates antipruritic effect in mild atopic dermatitis in phase III EPIONE study

Feb. 26, 2020

Novan gives update on the phase III B-SIMPLE program of SB-206

Feb. 7, 2020

New Trk-A, Trk-B and Trk-C inhibitors discovered at BenevolentAI Bio

Feb. 6, 2020

Aurigene initiates phase II study of AUR-101 in moderate to severe psoriasis

Feb. 4, 2020

German Medicines Agency approves phase II study of FOL-005

Jan. 31, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...